Studying lymph node spread in cancer using images
Part of Cancer, Skin clinical trials.
This study uses images of your removed lymph nodes to see if cancer has spread there. It may help doctors better understand your cancer without needing extra tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have one of the listed cancers: breast, thyroid, lung, esophagus, stomach, colorectal, prostate, bladder, or cervical.
- You must be planning to have surgery to remove the tumor and some lymph nodes.
- Your doctors must be able to get a clear final pathology report on the lymph nodes after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether substances called metabolites in your blood and breast tissue can help predict if breast cancer has spread to the first lymph node (sentinel node). If you are scheduled for breast cancer surgery and have not had prior treatment, the study team will use your blood and tissue samples to try to improve prediction.
This trial uses MRI scans to predict if breast cancer has spread to additional lymph nodes beyond the first one that was biopsied. It may help women who have already had a positive sentinel lymph node biopsy and then had more lymph nodes removed.
This study looks back at past MRI scans and lymph node biopsies or surgeries in people with breast cancer to better understand how cancer spreads to the lymph nodes. If you had these tests as part of your care, your data might help improve future treatment decisions.
This study uses a blood test and imaging to predict whether breast cancer has spread to underarm lymph nodes, helping guide surgery. It may reduce unnecessary lymph node removal.
This trial aims to find out if doing special scans to check for breast cancer spread to organs (not just lymph nodes) is helpful in certain patients. The study looks at people with breast cancer that had already spread to lymph nodes and did not completely go away with chemotherapy and surgery.
This trial compares three methods (LN-RADS, RECIST 1.1, and Node-RADS) to see which best evaluates lymph nodes in people with cancer. It may help doctors make more accurate decisions about your lymph nodes using CT or MRI scans.
Hear when a new Lymph Node Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.